Dr. Nancy Durand, FRCS, Gynaecologist

bh IN BRIEF   The first vaccine for Human Papilloma Virus (HPV) was released a year ago. In coming years, the targeted population will expand to include older women and boys. Federal funding of $300 million will have limited impact. Private drug plans often cover vaccines, and employers will be wrestling with the significant potential … Continue reading Dr. Nancy Durand, FRCS, Gynaecologist